Semler Scientific, Inc. (SMLR)

Inozyme Pharma Revenue

Semler Scientific had revenue of $8.84M in the quarter ending March 31, 2025, a decrease of -44.44%. This brings the company's revenue in the last twelve months to $49.23M, down -25.28% year-over-year. In the year 2024, Semler Scientific had annual revenue of $56.29M, down -17.44%.

• Revenue (ttm): $49.23M
• Revenue Growth: -25.28%
• P/S Ratio: 5.53
• Revenue / Employee: $623,114
• Employees: 79
• Market Cap: 799.04M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	56.29M	-11.89M	-17.44%
Dec 31, 2023	68.18M	11.50M	20.28%
Dec 31, 2022	56.69M	3.66M	6.90%
Dec 31, 2021	53.03M	14.42M	37.36%
Dec 31, 2020	38.60M	5.84M	17.81%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.